Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients

26 de septiembre de 2012 actualizado por: Centers for Disease Control and Prevention

Effectiveness of a Video-based Educational Intervention to Prevent Human Immunodeficiency Virus (HIV) and Sexually Transmitted Diseases (STDs) Among Patients Attending STD Clinics

The purpose of this study is to assess the effectiveness of a brief 23-minute video-based educational waiting room intervention to reduce incident STD and high risk behavior among STD patients attending STD clinics in three United States (U.S.) cities.

Descripción general del estudio

Descripción detallada

Approximately 15 million incident cases of sexually transmitted diseases (STDs) occur annually. As a result, primary prevention of HIV/STDs among persons who have chosen to be sexually active remains a high public health priority. A number of effective interventions to prevent HIV/STDs have been developed, however many require considerable time and resource investments from both service providers and participants. These programs are often difficult to implement and sustain over time. As a result, simple practical interventions that can reduce transmission or acquisition of HIV/STDs among STD clinic patients while being both easily implemented and sustainable are urgently needed, and will ultimately enhance the menu of effective programs that are currently available to the STD clinic population.

The intervention trial was designed to develop and evaluate a video-based HIV/STD prevention intervention for STD clinic clients. The primary goals of this study are to assess whether a brief video-based educational waiting room intervention can reduce STD incidence (STD incidence outcome study) and high risk behavior (behavioral outcome study) among male and female patients attending STD clinics, when compared with patients who receive standard clinic services. This study is being conducted as a multi-site trial in 3 urban STD clinics.

The intervention condition consists of a 23-minute educational video focused on preventing STD and HIV infection shown on a large television in the waiting room. Health promotion posters supplement the video. The control condition consists of the current standard waiting room experience in each city's STD clinic.

In the STD incidence outcome study, groups of patients attending the participating STD clinics are randomly assigned to blocks of clinic weeks to either the intervention or control condition. A waiver of informed consent was obtained whereby no subjects are actively enrolled for this phase of the study. Through a retrospective review of existing medical records and STD surveillance registry data, we will determine and compare the incidence of new STDs over a 12-month period (on average) by assigned waiting room conditions.

In the behavioral outcome study, investigators administer computer-based survey instruments to a random sample of ~1600 male and female patients (800 per arm) both at enrollment and at 3 months following their initial clinic visit. The primary objective of the behavioral study is to assess the effectiveness of the video intervention by comparing levels of high-risk behavior between waiting room conditions at 3 months' follow-up.

Tipo de estudio

Intervencionista

Inscripción

45000

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • California
      • Long Beach, California, Estados Unidos, 90815
        • California State University, Long Beach
      • San Francisco, California, Estados Unidos, 94103
        • San Francisco Department of Public Health
    • Colorado
      • Denver, Colorado, Estados Unidos, 80204
        • Denver Public Health
    • Massachusetts
      • Newton, Massachusetts, Estados Unidos, 02458
        • Education Development Center, Inc.

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

STD Incidence Outcome Study:

  • All medical records for STD clinic patients visiting participating STD clinics during the study period.

Behavioral Outcome Study:

STD clinic patients:

  • Not returning for a follow-up visit related to a previously diagnosed problem.
  • 18 years of age or older.
  • Not known to be HIV-infected by self-report.
  • Able to understand and speak English fluently.
  • Have not been previously seen as a patient in the clinic during an intervention block when the video was being played.
  • Have never received a diagnosis of a condition that necessitates frequent return visits (e.g., genital warts) by self-report.
  • Have not previously enrolled in the study.
  • Reported being in the clinic waiting room at least 20 minutes.
  • Do not plan to move outside the clinic's catchment area during the next 6 months.
  • Are willing to provide informed consent for review of their medical record and STD surveillance registry information by study staff.
  • Are not known to be pregnant according to self-report (women only).
  • Are not known by clinicians or counselors to be seriously ill (e.g. new HIV diagnosis or severe pelvic inflammatory disease [PID]).
  • Engaged in intercourse in the last three months.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Único

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
STD Incidence Outcome Study: Compare STD incidence in groups by intervention and control conditions at 3, 6, and 12 months follow-up
Behavioral Outcome Study: Compare the incidence of risk behavior during the 3 month follow-up period among intervention and control conditions

Medidas de resultado secundarias

Medida de resultado
STD Incidence Outcome Study: Compare incidence of STD syndromes, and first episode of genital herpes or genital warts in intervention/control conditions
Behavioral Outcome Study: Compare additional measures of risk between intervention and control conditions at three months follow-up including potential mediators of risk and clinic utilization

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Jeff D Klausner, MD, MPH, San Francisco Department of Public Health/ STD Prevention and Control Services
  • Investigador principal: Cornelis A Rietmeijer, MD, PhD, Denver Public Health
  • Investigador principal: Kevin Malotte, DrPH, California State University, Long Beach
  • Investigador principal: Lydia N O'Donnell, Ed.D., Education Development Center, Inc.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de abril de 2002

Finalización primaria (Actual)

1 de marzo de 2006

Finalización del estudio (Actual)

1 de marzo de 2009

Fechas de registro del estudio

Enviado por primera vez

27 de agosto de 2005

Primero enviado que cumplió con los criterios de control de calidad

27 de agosto de 2005

Publicado por primera vez (Estimar)

30 de agosto de 2005

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

27 de septiembre de 2012

Última actualización enviada que cumplió con los criterios de control de calidad

26 de septiembre de 2012

Última verificación

1 de septiembre de 2012

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • CDC-NCHSTP-3500
  • R18/CCR921007
  • R18/CCR121005
  • R18/CCR821004

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir